SPRB · Spruce Biosciences Inc
United States · RS rating 27 · As of 2026-11-03
| Price | 42.81 USD |
|---|---|
| 1-day change | -3.9% |
| RS rating (overall / 1M / 3M / 12M) | 27 / 43 / 49 / 16 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 30 / 8 / 49 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +25.3% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +66.3% |
| Market cap (USD) | $146.0M |